Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1983 1
1984 1
1986 1
1987 1
1989 2
1991 1
1992 4
1993 2
1996 1
1997 2
2000 2
2001 1
2002 1
2003 2
2004 2
2005 3
2009 2
2010 4
2011 2
2012 4
2013 4
2014 3
2016 1
2017 3
2018 2
2019 5
2020 2
2021 1
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Management of Stromal Lesions.
Yu J, Kansal K. Yu J, et al. Surg Clin North Am. 2022 Dec;102(6):1017-1030. doi: 10.1016/j.suc.2022.07.002. Surg Clin North Am. 2022. PMID: 36335922 Review.
Breast stromal lesions include fibroadenomas, phyllodes tumors, pseudoangiomatous stromal hyperplasia, periductal stromal tumors, and lipomas. Most of these lesions are benign and can be managed with observation or surgical excision. ...
Breast stromal lesions include fibroadenomas, phyllodes tumors, pseudoangiomatous stromal hyperplasia, periductal stromal tumo …
Pseudoangiomatous stromal hyperplasia of the breast: Clinical evaluation.
Esmer AC, Tazeoglu D, Dag A. Esmer AC, et al. Breast Dis. 2023;42(1):115-119. doi: 10.3233/BD-220070. Breast Dis. 2023. PMID: 37066901
BACKGROUND: Pseudoangiomatous stromal hyperplasia is a rare benign breast stromal proliferative lesion of the breast. ...Pseudoangiomatous Stromal Hyperplasia is not a risk factor for developing breast cancer....
BACKGROUND: Pseudoangiomatous stromal hyperplasia is a rare benign breast stromal proliferative lesion of the breast. ...Pseud …
Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics.
Jorns JM, Farooq A, Puzyrenko A, Jarzembowski J, Thike AA, Nasir NDM, Ng CCY, Liu W, Lee JY, Lim AH, Guan P, Teh BT, Tan PH. Jorns JM, et al. Histopathology. 2023 Sep;83(3):357-365. doi: 10.1111/his.14935. Epub 2023 May 4. Histopathology. 2023. PMID: 37140543
Giant (G) JFA, like other FEL, may exhibit prominent pseudoangiomatous stromal hyperplasia (PASH)-like change. We sought to determine clinicopathological and molecular characteristics of GJFA with and without PASH. ...MED12 mutation was identified in one case. TERT …
Giant (G) JFA, like other FEL, may exhibit prominent pseudoangiomatous stromal hyperplasia (PASH)-like change. We sought to de …
Pseudoangiomatous stromal hyperplasia: A clinical perspective and a brief review.
Patel G, Bipte S, Narurkar S. Patel G, et al. J Cancer Res Ther. 2023 Oct 1;19(7):1714-1720. doi: 10.4103/jcrt.jcrt_127_22. Epub 2023 Jan 3. J Cancer Res Ther. 2023. PMID: 38376269 Free article. Review.
Pseudoangiomatous stromal hyperplasia (PASH) is a benign entity of the breast and typically found incidentally or as a palpable mass. ...PASH lesions should be surgically excised if increasing in size or associated with symptoms, also in cases of suspicious imaging …
Pseudoangiomatous stromal hyperplasia (PASH) is a benign entity of the breast and typically found incidentally or as a palpabl …
Myofibroblastic, fibroblastic and myoid lesions of the breast.
Krings G, McIntire P, Shin SJ. Krings G, et al. Semin Diagn Pathol. 2017 Sep;34(5):427-437. doi: 10.1053/j.semdp.2017.05.010. Epub 2017 May 28. Semin Diagn Pathol. 2017. PMID: 28751104 Review.
Whereas most have similar features to their counterparts at extramammary sites, pseudoangiomatous stromal hyperplasia is considered a breast-specific myofibroblastic proliferation on the same spectrum as myofibroblastoma. ...
Whereas most have similar features to their counterparts at extramammary sites, pseudoangiomatous stromal hyperplasia is consi …
Upstaging of Fibroepithelial Lesions: A Single-Institution Experience.
Mohan SC, Tseng J, Marumoto A, Angarita S, Dadmanesh F, Amersi F, Giuliano A, Chung A. Mohan SC, et al. Ann Surg Oncol. 2022 Apr;29(4):2193-2199. doi: 10.1245/s10434-021-10931-0. Epub 2021 Oct 20. Ann Surg Oncol. 2022. PMID: 34671884
The purpose of this study was to determine the features of FEL on CNB that may be predictive of PT, the upstage rate to PT after excision, and the outcomes of those who did not undergo excision. ...Pathology on CNB included 97 cases of FEL favoring FA, 19 cases of FEL favo …
The purpose of this study was to determine the features of FEL on CNB that may be predictive of PT, the upstage rate to PT after exci …
Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma.
Reijnen C, Küsters-Vandevelde HVN, Abbink K, Zusterzeel PLM, van Herwaarden AE, van der Laak JAWM, Massuger LFAG, Snijders MPLM, Pijnenborg JMA, Bulten J. Reijnen C, et al. Hum Pathol. 2019 Mar;85:119-127. doi: 10.1016/j.humpath.2018.10.022. Epub 2018 Nov 11. Hum Pathol. 2019. PMID: 30428390
Endometrioid endometrial carcinomas (EECs) are correlated with high serum levels of androgens and estrogen. We hypothesized that Leydig cells and ovarian stromal hyperplasia contribute to postmenopausal ovarian androgen production and are observed more freque …
Endometrioid endometrial carcinomas (EECs) are correlated with high serum levels of androgens and estrogen. We hypothesized that Leydig cell …
Pseudoangiomatous stromal hyperplasia and breast cancer risk.
Degnim AC, Frost MH, Radisky DC, Anderson SS, Vierkant RA, Boughey JC, Pankratz VS, Ghosh K, Hartmann LC, Visscher DW. Degnim AC, et al. Ann Surg Oncol. 2010 Dec;17(12):3269-77. doi: 10.1245/s10434-010-1170-5. Epub 2010 Jun 22. Ann Surg Oncol. 2010. PMID: 20567920 Free PMC article.
BACKGROUND: Pseudoangiomatous stromal hyperplasia (PASH) is a benign localized fibrotic lesion in which clusters of spindle cells form cleftlike spaces, resembling ectatic vessels. ...Relative risks for subsequent breast cancer were estimated using standardized inci …
BACKGROUND: Pseudoangiomatous stromal hyperplasia (PASH) is a benign localized fibrotic lesion in which clusters of spindle ce …
Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
Cui Y, Han S, Liu M, Wu PY, Zhang W, Zhang J, Li C, Chen M. Cui Y, et al. J Magn Reson Imaging. 2020 Aug;52(2):552-564. doi: 10.1002/jmri.27075. Epub 2020 Feb 6. J Magn Reson Imaging. 2020. PMID: 32027071
ASSESSMENT: Four kinds of tissue types were identified on pathology, including PCa, stromal hyperplasia (SH), glandular hyperplasia (GH), and noncancerous peripheral zone (PZ). PCa foci were grouped as low-grade (LG, Gleason score 6) and intermediate/high-gra …
ASSESSMENT: Four kinds of tissue types were identified on pathology, including PCa, stromal hyperplasia (SH), glandular hyperp …
Ovarian Tissue Culture to Preserve Fertility in Transgender Male Patients after Hormonal Treatment.
Bottini AL, Reis VMSFD, Capp E, Silva ISBD, Kliemann LM, Corleta HVE. Bottini AL, et al. Rev Bras Ginecol Obstet. 2022 Mar;44(3):251-257. doi: 10.1055/s-0042-1742410. Epub 2022 Feb 9. Rev Bras Ginecol Obstet. 2022. PMID: 35139567 Free PMC article.
The ovarian cortex was cut into fragments of 2 mm, 3 mm, and 4 mm, and placed in a 96-well plate suitable for cultivation at days 0, 2, 4, 6, and 8, when the histology was analyzed. RESULTS: Stromal hyperplasia was observed in all samples, and it was not asso …
The ovarian cortex was cut into fragments of 2 mm, 3 mm, and 4 mm, and placed in a 96-well plate suitable for cultivation at days 0, 2, 4, 6 …
63 results